Cohance Lifesciences Limited has informed the Exchange about General Updates
COHANCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Cohance Lifesciences Limited (formerly Suven Pharmaceuticals Limited), at its meeting held on June 26, 2025, approved two items. First, it appointed M/s Makarand M Joshi & Co. (MMJC), a peer-reviewed firm of Practicing Company Secretaries with over 25 years of experience, as the company's Secretarial Auditors for a term of five consecutive years from FY2025-26 to FY2029-30, subject to shareholder approval at the upcoming AGM. Second, the Board fixed Friday, September 19, 2025 as the date for the 7th Annual General Meeting of the company.
This is a routine corporate governance update with no material impact on shareholders. The appointment of an experienced secretarial auditor for a five-year term reinforces compliance standards, and the AGM date gives shareholders clarity on the upcoming shareholder meeting.